Sherry Condie

Sherry Condie, RAC, currently serves as Senior Director of CMC Regulatory Affairs at Centessa Pharmaceuticals, beginning in September 2023. Previously, Sherry held roles at Mirum Pharmaceuticals, where responsibilities included leading CMC regulatory strategy as Associate Director and Senior Manager from April 2021 to September 2023. Prior experience includes positions at Regeneron, overseeing a team in CMC regulatory sciences, and at Rhodes Pharmaceuticals, compiling CMC documentation. Sherry’s early career involved regulatory affairs at X-GEN Pharmaceuticals and various roles in animal care and pharmacy settings. Sherry holds a Bachelor's Degree in Biochemistry from Elmira College.